These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3201896)

  • 1. Successful treatment of a patient with acute myeloid leukemia with 1 alpha(OH)D3.
    Nakayama S; Ishikawa T; Yabe H; Nagai K; Kasakura S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1026-30. PubMed ID: 3201896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 (1 alpha(OH)D3)].
    Taoka T; Hamamoto T; Okuda Y; Hata Y; Kubota Y; Tanaka T; Irino S; Miyazaki T; Ohbayashi S
    Rinsho Ketsueki; 1987 Jun; 28(6):830-8. PubMed ID: 3478504
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
    Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
    Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose ARA-C and 1(OH) D3 administration in acute non lymphoid leukemia: pilot study.
    Petrini M; Caracciolo F; Corini M; Valentini P; Sabbatini AR; Grassi B
    Haematologica; 1991; 76(3):200-3. PubMed ID: 1660439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]].
    Irino S; Taoka T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
    Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
    Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose 1-hydroxyvitamin D3 in a patient with myelodysplasia after induction therapy for acute myelocytic leukemia.
    Fujisawa S; Motomura S; Sakai R; Tomita N; Fujimaki K; Mohri H; Okubo T
    Anticancer Drugs; 1997 Jun; 8(5):466-7. PubMed ID: 9215609
    [No Abstract]   [Full Text] [Related]  

  • 8. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP; Hirji K; Itri L
    Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.
    Orimo H; Shiraki M; Hayashi T; Nakamura T
    Bone Miner; 1987 Oct; 3(1):47-52. PubMed ID: 3505192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.
    Blazsek I; Musset M; Boulé D; Labat ML; Bringuier MF; Comisso M; Le Maignan C; Ribaud P; Mathé G; Misset JL
    Cancer Detect Prev; 1992; 16(4):259-64. PubMed ID: 1458517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating 1 alpha,25-dihydroxyvitamin D levels after a single dose of 1 alpha,25-dihydroxyvitamin D3 or 1 alpha-hydroxyvitamin D3 in normal men.
    Seino Y; Tanaka H; Yamaoka K; Yabuuchi H
    Bone Miner; 1987 Sep; 2(6):479-85. PubMed ID: 3505770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced myelodysplastic syndrome with alfacalcidol.
    Mehta AB; Kumaran TO; Marsh GW; McCarthy DM
    Lancet; 1984 Sep; 2(8405):761. PubMed ID: 6148516
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of active vitamins D3, 1 alpha-hydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in patients on chronic hemodialysis.
    Kimura Y; Nakayama M; Kuriyama S; Watanabe S; Kawaguchi Y; Sakai O
    Clin Nephrol; 1991 Feb; 35(2):72-7. PubMed ID: 2019017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitamin D-resistant rickets type II: apropos of 2 cases].
    Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
    Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of antiepileptic drug-induced osteomalacia with 1 alpha-OH vitamin D3 (alpha-D3)].
    Maeda K; Ikeda H; Fijita T
    Rinsho Shinkeigaku; 1983 Mar; 23(3):253-8. PubMed ID: 6600150
    [No Abstract]   [Full Text] [Related]  

  • 16. 1 alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts.
    Hyodo H; Kimura A; Nakata Y; Ohta H; Kuramoto A
    Int J Hematol; 1993 Apr; 57(2):131-7. PubMed ID: 8388271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
    Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic inhibition of tumor promoter-induced ornithine decarboxylase in 1 alpha-hydroxyvitamin D3-treated animals.
    Hashiba H; Fukushima M; Chida K; Kuroki T
    Cancer Res; 1987 Oct; 47(19):5031-5. PubMed ID: 3621189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1 alpha(OH)D3 treatment and procollagen III (PC III) studies in idiopathic myelofibrosis.
    Tsatalas C; Curtoglou G; Fotopoulos D; Halkia P; Vyzantiadis AT; Sinakos Z
    Haematologica; 1989; 74(6):559-62. PubMed ID: 2628238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [1 alpha(OH) D3 (Alfarol) is effective for the treatment of chronic B cell leukemia: a case report].
    Hashimoto E; Takeuchi H; Saitou M; Hirashima K
    Rinsho Ketsueki; 1989 Oct; 30(10):1876-80. PubMed ID: 2593255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.